Table 1 Baseline data
From: Prophylactic anticoagulation in nephrotic syndrome prevents thromboembolic complications
Demographics | Anticoagulation | Non-anticoagulation | p-value |
|---|---|---|---|
Number | 44 | 35 | |
Male, n (%) | 26 (59) | 13 (37) | 0.053 |
Median age (year, range) | 43 (17–78) | 52 (22–84) | |
Median serum creatinine (μmol/L, range) | 83 (37–547) | 107 (43–208) | |
Plasma albumin (g/L, range) | 15 (10–23) | 20 (11–29) | < 0.001 |
Duration of treatment (days) | 26 (1–350) | – | – |
Follow-up time (weeks, IQR) | 92 (34–178) | 49 (19–98) | 0.19 |